Apolipoprotein E polymorphism in middle-aged Belgian men: Phenotype distribution and relation to serum lipids and lipoproteins

Atherosclerosis

Volumn 120, Issue 1-2, 1996, Pages 67-73

  Braeckman, L ^a   De Bacquer, D ^a   Rosseneu, M ^a   De Backer, G ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Apo E polymorphism; Epidemiology; Lifestyle; Lipoproteins

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BELGIUM; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030019858     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05681-5     Document Type: Article

References (30)

1. World Health Organization. World Health Statistics Annual 1993. Geneva: WHO, 1994.
2. The WHO MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Stat Q 1988;41:115.
3. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 1977;269:604.
4. Zannis I, Just PW, Breslow JL. Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 1981;33:11.
5. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988;8:1.
6. Weisgraber K, Rall S, Innerarity T, Mahley R, Kuusi T, Ehnholm C. A novel electrophoretic variant of human apolipoprotein: identification and characterization of apolipoprotein EI. J Clin Invest 1984;73:1024.
7. Yamamura T, Yamamota A, Sumiyoshi T, Hiramori K, Nishioeda Y, Nambu S. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia. J Clin Invest 1984;74:1229.
8. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985;37:268.
9. Boerwinkle E, Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B and cholesterol metabolism. Am J Hum Genet 1988;42:104.
10. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433.
11. Smit M, de Knijff P, Rosseneu M, Bury J, Klasen E, Frants R, Havekes M. Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet 1988;80:287.
12. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis. J Lipid Res 1992;33:447.
13. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993;39:2125.
14. de Knijff P, Johansen L, Rosseneu M, Frants R, Jespersen J, Havekes L. Lipoprotein profile of a Greenland Inuit population. Arteriosclerosis Thromb 1992;12:1371.
15. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338.
16. Luc G, Bard J-M, Arveiler D et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study. Arteriosclerosis Thromb 1994;14:1412.
17. Tiret L, de Knijff P, Menzel H-J, Ehnholm C, Nicaud V, Havekes L. Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. Arteriosclerosis Thromb 1994;14:1617.
18. Havekes L, de Knijff P, Reisiegel U, Havinga J, Smit M, Klasen E. A rapid micro-method for apolipoprotein E phenotyping directly in serum. J Lipid Res 1987;28:445.
19. Gudnason V, Sigurdsson G Jr, Steingrimsdottir L, Humphries S, Sigurdson G. Association of apo E polymorphism with plasma levels of high density lipoprotein and lipoprotein(a), and effect of diet in healthy men and women. Nutr Metab Cardiovasc Dis 1993;3:136.
20. Rosseneu M, Vinaimont N, Vercaemst R, De Keersgieter W, Belpaire F. Standardization of immunoassays for the quantification of plasma apo B protein. Anal Biochem 1981;116:204.
21. Bury J, Vercaemst R, Rosseneu M, Belpaire F. Apolipoprotein E quantified by enzyme-linked immunosorbent assay. Clin Chem 1986;32:265.
22. Guo SW, Thompson EA. Performing the exact test for Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361.
23. SAS/STAT User's Guide, Release 6-04 Edition. Cary, NC: SAS Institute Inc., 1988.
24. Pouliot M-C. Després J-P, Moorjani S, Lupien PJ, Tremblay A, Bouchard C. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J Lipid Res 1990;31:1023.
25. Després J-P, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol Cell Biochem 1992;113:151.
26. Després J-P, Verdon M-F, Moorjani S et al. Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia. Diabetes 1993;42:1474.
27. Wilson PWF, Garrison RJ, Abbott RD, Castelli WP. Factors associated with lipoprotein cholesterol levels. The Framingham Study. Arteriosclerosis 1983;3:273.
28. Chambless L, Döring A, Filipiak B, Keil U. Determinants of HDL cholesterol and the HDL cholesterol/total cholesterol ratio. Results from the Lübeck blood pressure study. Int J Epidemiol 1990;19:578.
29. Wannamethee G, Shaper AG. Blood lipids: the relationship with alcohol intake, smoking, and body weight. J Epidemiol Community Health 1992;46:197.
30. Marti B, Suter E, Riesen WF, Tschopp A, Wanner HU. Anthropometric and lifestyle correlates of serum lipoprotein and apolipoprotein levels among normal nonsmoking men and women. Atherosclerosis 1989;75:111.